Tag Archives: healthcare

Chinese Experts Agree on the Benefit of EECP® in Treating Stroke Patients

Last week, an expert panel of physicians in China published an article titled Chinese Consensus Statement on the Evaluation and Intervention of Collateral Circulation for Ischemic Stroke under a Clinical Guideline in CNS Neuroscience & Therapeutics, a peer reviewed scientific journal. The article is based on the group’s review of the most up-to-date evidence-based clinical research and their state-of-the-art, scientific knowledge on ischemic stroke.

In their summary, the authors make the point that “Collateral circulation is becoming more significant in the individual management strategy for ischemic stroke…” and that current data has been recently updated to reflect this. They further note – in the section discussing Indirect Interventions that External Counterpulsation “…increases cardiac output and augments blood flow of vital organs, such as brain, kidney, liver, and myocardium.”

One of the additional recent updates is the inclusion of EECP (Enhanced External Counterpulsation) Therapy in the 2012 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, with a IIb Level of Recommendation (LOR).

Though the use of EECP Therapy is not yet an approved Indication for Use by the U.S. Food and Drug Administration, recently published papers show that recognition of the clinical benefits of EECP Therapy in treating stroke patients by experts in the field are encouraging that one day, in the not too distant future, it will be.

Tales from the Road: Thoughts After a Successful Show at the 2014 Arab Health Exhibition & Congress

We consider our exhibition at Arab Health last week to be one of our most successful tradeshows to date. This was largely accredited to our new Vasomedical exhibition booth and our strategic location at the show. The live demonstrations of EECP® Therapy generated large audiences and the booth’s visibility and new look were better at displaying our EECP Therapy and Biox patient monitoring products.

Attendees going to and from different exhibition halls, meetings and presentations stopped in our booth as they walked through the main concourse.  They wanted to know more about EECP® Therapy, the Biox ECG Holter and ambulatory blood pressure monitors, and our new wireless MobiCare® patient monitors. From the moment the exhibition halls opened to after the exhibit halls closed, our booth continued to stay busy.

At the show we spoke with an extensive number of physicians, distributors, hospital, and health ministry personnel from all of the countries in the Middle East and many different countries in Africa, as well as representatives from India during the four days of the exhibition.

Arab Health was a very successful meeting where we generated many leads, captivated lots of interest, and educated global medical industry leaders unfamiliar with EECP Therapy.  All the people we met in Dubai were warm and friendly and one gets the sense of being in a melting pot that is open to innovative medical technologies like EECP Therapy.

We look forward to working with many of the people we met at the show to bring our products to more patients in the Middle East region, Africa and Southeast Asia.

Tales from the Heart: Heart House in Washington Township Edition

Across the country there are heart clinics and cardiologists dedicated to providing the best in EECP Therapy to patients who suffer from heart disease. This week, we wanted to shine the spotlight on Heart House in Washington Township and Dr. Scott Fertels, a cardiologist with Cardiovascular Associates of the Delaware Valley, New Jersey.

Dr. Fertels witnessed remarkable patient progress as a result of undergoing treatment with EECP Therapy. He writes:

“One of our patients, an 82-year old gentleman with a history of coronary artery bypass and prior intracoronary stents was even able to go jogging without chest pain, fatigue or shortness of breath after completing his EECP treatment.”

EECP Therapy has changed lives. Dr. Fertels receives thank you letters all the time but one note he received from a 68-year old patient with advanced heart disease was particularly poignant:

“She wrote that prior to receiving EECP Therapy; she was constantly overwhelmed by fatigue and discomfort, unable to travel to the supermarket without needing to spend the entire day recovering in bed. After completing the entire EECP treatment protocol, her energy level was so improved that she decided to take a 300 mile trip to be with friends at her 50 year high school reunion.”

Dr. Fertels is an advocate for EECP Therapy because he has seen patient improvements with his own eyes.

There are many more heartwarming stories of recovery written every day, and we look forward to bringing them to you via the blog. If you have a story about EECP Therapy you’d like to share, please email us at: vaso@kcsa.com.

 

Tales from the Heart – EECP® on Prime Time TV

Last week in Los Angeles, TV station KTLA ran a live broadcast from Global Cardio Care, an Inglewood based EECP® therapy clinic that has been treating patients with cardiovascular disease since 2002. Sara Soulati, founder of Global Cardio Care has been treating patients since 1996 when she launched her career in the field of EECP® therapy. After treating thousands of patients successfully in her West LA location Sara opened up a second center in 2012 in the Wilshire area of West LA.

Sara’s centers offer a healthy life style program featuring EECP® therapy, plant-based nutrition and exercise. EECP® therapy, an FDA cleared therapy for the treatment of angina and used for other cardiovascular diseases as well, has been clinically proven though still remains relatively unknown. You can visit the KTLA web site and read the story as well as see the videos of the segments on EECP® therapy as seen by the public in the Los Angeles viewing area last Friday.

It was so well viewed in Los Angeles that Jay Leno used a sequence shot in his ‘Looks Dirty But It’s Not” comedy routine. Hopefully this exposure on KTLA can help make more patients aware of the therapy and increase their interest to find access to a therapy center near them. As Gayle and Sara demonstrated, you may find that EECP® therapy can create a New Year! New You!

EECP Therapy and Stroke Patients

There are an estimated 6.8 million Americans over 20 years old who have had a stroke, and 795,000 people experience a new or recurrent stroke every year.

Recently, there were several papers published to discuss the effects of using External Counterpulsation (ECP) therapy to treat ischemic stroke patients with cerebral large artery disease. The effects of ECP  as a treatment of acute stroke has been demonstrated to increase cerebral blood pressure and blood flow velocity in stroke patients previously. ECP has been used extensively to help functional recovery of ischemic stroke patients in China, even though it has not been cleared by FDA for treatment of this cohort of patients in the United States.

In brief, these papers have the following message:

  • The first paper analyzed 207 ischemic stroke patients, with 112 patients completed the 35 hour session of ECP, 43 did not, and 52 medical treated patients served as controls. Three months after a stroke, 70.5% of the patients who finished a whole course of EECP had a good clinical outcome, whereas only 46.5% achieved good outcome in the unfinished ECP group and 38.5% in the medical group. Patients with good clinical outcome were younger, had a lower baseline National Institute of Health Stroke Scale and longer ECP therapy. The paper concluded that the duration of ECP therapy is an important factor for a good clinical outcome.
  • The second paper published demonstrated that ECP treatment increased cerebral blood pressure significantly as well as blood flow velocity in both sides of the brain in 37 recent ischemic stroke patients with large artery occlusive disease but not in the 20 healthy controls. The study demonstrated that ECP can increase blood flow to both sides of the cerebral hemisphere presumably because the cerebral autoregulation was impaired soon after stroke.
  • The third paper published investigated the relationship between the magnitudes of external applied pressures during ECP, resulting in increased cerebral perfusion pressures and increased mean cerebral blood flow in 38 ischemic stroke patients and 20 elderly controls. The mean blood pressure increased significantly from baseline in both stroke and control groups in proportion to external applied pressure, whereas the mean cerebral blood flow increased to the same levels of around 5% above baseline in the stroke patients independent of the external applied pressure. Also, there were no changes in blood flow in the control group under different magnitudes of external applied pressure. The paper recommended 150 mm Hg as the optimal treatment pressure for ischemic stroke patients.

Dr. John CK Hui of Vasomedical remarked:  “It has been postulated for decades that increase in cerebral perfusion blood pressure and blood flow would improve the functional recovery rate of stroke patients. These recent papers provided evidence that ECP treatment within the first two weeks after stroke when the autoregulatory response is inactive is safe and effective in augmenting cerebral blood pressure and flow. Results of these studies were encouraging and they stimulate us to start developing protocols for studies to seek FDA labeling clearance for stroke patients.”

Bringing EECP Therapy to the Forefront

EECP Therapy has been available to treat patients with heart issues since the mid-nineties and its forerunner “external counterpulsation” dates back to the 1970s but even after all this time there unfortunately remains a lack of awareness about the treatment, and many patients suffering with heart disease remain unaware of EECP Therapy and the benefits it offers.

We wanted to share a piece with you which originally appeared in Easy Health Options from Bob Livingston, a dedicated researcher who specializes in health issues and searching for alternatives to mainstream treatments, wrote about EECP Therapy. This piece shines further light on this low-cost, effective treatment for heart disease.

When discussing how patients received the treatments, Livingston writes:

“The testimonials of patients with severe angina are full of the highest praise. I have talked to one extremely serious heart patient who called EECP a miracle. He was an invalid, yet now he’s back to life — even playing golf.”

From all of his years of research, Livingston has become a firm believer in EECP Therapy:

“I suggest you pursue EECP evaluation by a cardiologist to make sure that you aren’t excluded. If your cardiologist is indifferent to EECP, then get another cardiologist.”

It’s important for us when raising awareness of EECP Therapy to tell stories that spotlight the treatment’s loyal supporters and patients who have received benefits from this therapy.

There are countless patient stories and supporters out there, and bringing those stories with us to conferences, meetings and our office lives makes our jobs more rewarding and enjoyable. If you or someone you know has a story to tell about EECP Therapy, we’d love to hear from you!  You can email us at vaso@kcsa.com.